Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives
- PMID: 16978759
- DOI: 10.1016/j.tox.2006.08.004
Pharmacokinetic modeling of saturable, renal resorption of perfluoroalkylacids in monkeys--probing the determinants of long plasma half-lives
Abstract
Perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) compounds associated with surface protection product manufactures are distributed globally. The 3-5-year half-lives, reproductive and liver toxicity in animals, and lack of understanding of the factors regulating retention in the body have led to a world-wide public concern for use of these materials. Using a novel physiologically-motivated pharmacokinetic model for renal clearance, perfluoroalkylacid pharmacokinetics in monkeys was successfully described by renal resorption via high efficiency transporters for both intravenous and oral dosing. Intravenous dosing with both PFOA and PFOS in Cynomolgus monkeys produced time course curves consistent with a two-compartment distribution. Extending the PK model for intravenous dosing to examine blood and urine time course data for repeated oral dosing clearly identified the saturable renal resorption. Resorption depends on kinetic factors for transport (T(mC), transport maximum; K(T), transport affinity) and free fraction in plasma (f(plasma)). For PFOA, these parameters were estimated to be 5mg/(h kg) (T(mC)), 0.055 mg/L (K(T)), and 0.02 (f(plasma)). PFOS has longer half-life and had respective values of 13.6 mg/(h kg), 0.023 mg/L, and 0.025. PFOS appeared to have a higher transport capacity and lower affinity than PFOA. Human kinetics indicates even higher resorption efficiency.
Similar articles
-
Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice, and monkeys.Reprod Toxicol. 2012 Jul;33(4):428-440. doi: 10.1016/j.reprotox.2011.07.002. Epub 2011 Aug 11. Reprod Toxicol. 2012. PMID: 21889587
-
Time dependencies in perfluorooctylacids disposition in rat and monkeys: a kinetic analysis.Toxicol Lett. 2008 Feb 28;177(1):38-47. doi: 10.1016/j.toxlet.2007.12.007. Epub 2007 Dec 27. Toxicol Lett. 2008. PMID: 18242015
-
Comparison and evaluation of pharmacokinetics of PFOA and PFOS in the adult rat using a physiologically based pharmacokinetic model.Reprod Toxicol. 2012 Jul;33(4):452-467. doi: 10.1016/j.reprotox.2011.04.006. Epub 2011 May 4. Reprod Toxicol. 2012. PMID: 21565266
-
Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model.Regul Toxicol Pharmacol. 2011 Feb;59(1):157-75. doi: 10.1016/j.yrtph.2010.12.004. Regul Toxicol Pharmacol. 2011. PMID: 21168463
-
Renal clearance of perfluorooctane sulfonate and perfluorooctanoate in humans and their species-specific excretion.Environ Res. 2005 Oct;99(2):253-61. doi: 10.1016/j.envres.2004.12.003. Epub 2005 Jan 18. Environ Res. 2005. PMID: 16194675
Cited by
-
Bioaccumulation of perfluoroalkyl acids in dairy cows in a naturally contaminated environment.Environ Sci Pollut Res Int. 2013 Nov;20(11):7959-69. doi: 10.1007/s11356-013-1722-x. Epub 2013 May 4. Environ Sci Pollut Res Int. 2013. PMID: 23644948
-
Development and Evaluation of Aquatic and Terrestrial Food Web Bioaccumulation Models for Per- and Polyfluoroalkyl Substances.Environ Sci Technol. 2024 Oct 8;58(40):17828-17837. doi: 10.1021/acs.est.4c02134. Epub 2024 Sep 26. Environ Sci Technol. 2024. PMID: 39327829 Free PMC article.
-
Per- and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research.Environ Toxicol Chem. 2021 Mar;40(3):606-630. doi: 10.1002/etc.4890. Epub 2020 Dec 7. Environ Toxicol Chem. 2021. PMID: 33017053 Free PMC article. Review.
-
Half-life of serum elimination of perfluorooctanesulfonate,perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers.Environ Health Perspect. 2007 Sep;115(9):1298-305. doi: 10.1289/ehp.10009. Environ Health Perspect. 2007. PMID: 17805419 Free PMC article.
-
Effect of potassium perfluorooctanesulfonate, perfluorooctanoate and octanesulfonate on the phase transition of dipalmitoylphosphatidylcholine (DPPC) bilayers.Biochim Biophys Acta. 2007 May;1768(5):1299-308. doi: 10.1016/j.bbamem.2007.02.003. Epub 2007 Feb 9. Biochim Biophys Acta. 2007. PMID: 17349969 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources